JD Health International Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a JDHIY research report →
Companyir.jdhealth.com
JD Health International Inc. , an investment holding company, operates an online healthcare platform in the People's Republic of China. It offers pharmaceutical and healthcare products, including OTC drugs, prescription drugs, and medical devices and supplies, as well as health supplements and tonics through direct selling and an online retail pharmacy network.
- CEO
- Cao Dong
- IPO
- 2022
- Employees
- 3,564
- HQ
- Beijing, CN
Price Chart
Valuation
- Market Cap
- $21.95B
- P/E
- 20.85
- P/S
- 1.53
- P/B
- 1.86
- EV/EBITDA
- 20.47
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 24.78%
- Op Margin
- 5.17%
- Net Margin
- 7.32%
- ROE
- 9.11%
- ROIC
- 5.53%
Growth & Income
- Revenue
- $71.44B · 22.83%
- Net Income
- $5.23B · 25.64%
- EPS
- $1.68 · 27.27%
- Op Income
- $3.69B
- FCF YoY
- -100.00%
Performance & Tape
- 52W High
- $9.08
- 52W Low
- $5.10
- 50D MA
- $6.90
- 200D MA
- $8.21
- Beta
- 1.13
- Avg Volume
- 11
Get TickerSpark's AI analysis on JDHIY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our JDHIY Coverage
We haven't published any research on JDHIY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate JDHIY Report →